APO RESEARCH · REPORT
NK Cell Therapy
Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
Product & engineering
Understand the product.
Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
Selected research
Industry Growth & Trends
Global NK Cell Therapy Industry Growth and Trends Forecast to 2032
Market perspective
Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
According to APO Research, the global NK Cell Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global NK Cell Therapy market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The NK Cell Therapy market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global NK Cell Therapy market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to NK Cell Therapy.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global NK Cell Therapy market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
NK Cell Therapy Market by Company
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Fate Therapeutics
Glycostem Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
NantWorks
Nkarta Therapeutics
Fortress Biotech
NK Cell Therapy Segment by Type
NK Cell Therapies
NK Cell Directed Antibodies
NK Cell Therapy Segment by Application
Cancer
Gastrointestinal Diseases
Others
NK Cell Therapy Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NK Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of NK Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NK Cell Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of NK Cell Therapy companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- NK Cell Therapies
- NK Cell Directed Antibodies
Applications
- Cancer
- Gastrointestinal Diseases
- Others
Companies covered
- Nektar Therapeutics
- Innate Pharma SA
- Affimed
- Chipscreen Biosciences
- Fate Therapeutics
- Glycostem Therapeutics
- Dragonfly Therapeutics
- Kiadis Pharma
- NantWorks
- Nkarta Therapeutics
- Fortress Biotech
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global NK Cell Therapy Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global NK Cell Therapy Market Size by Region (2021-2032)
- 1.4.1 Global NK Cell Therapy Market Size by Region (2021-2026)
- 1.4.2 Global NK Cell Therapy Market Size by Region (2027-2032)
- 1.5 Key Regions NK Cell Therapy Market Size (2021-2032)
- 1.5.1 North America NK Cell Therapy Market Size Growth Rate (2021-2032)
- 1.5.2 Europe NK Cell Therapy Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific NK Cell Therapy Market Size Growth Rate (2021-2032)
- 1.5.4 South America NK Cell Therapy Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa NK Cell Therapy Market Size Growth Rate (2021-2032)
2 NK Cell Therapy Market by Type
- 2.1 Type Introduction
- 2.1.1 NK Cell Therapies
- 2.1.2 NK Cell Directed Antibodies
- 2.2 Global NK Cell Therapy Market Size by Type
- 2.2.1 Global NK Cell Therapy Market Size Overview by Type (2021-2032)
- 2.2.2 Global NK Cell Therapy Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global NK Cell Therapy Market Size Forecasted by Type (2027-2032)
- 2.3 Global NK Cell Therapy Market Size by Regions
- 2.3.1 North America NK Cell Therapy Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe NK Cell Therapy Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific NK Cell Therapy Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America NK Cell Therapy Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa NK Cell Therapy Market Size Breakdown by Type (2021-2026)
3 NK Cell Therapy Market by Application
- 3.1 Type Introduction
- 3.1.1 Cancer
- 3.1.2 Gastrointestinal Diseases
- 3.1.3 Others
- 3.2 Global NK Cell Therapy Market Size by Application
- 3.2.1 Global NK Cell Therapy Market Size Overview by Application (2021-2032)
- 3.2.2 Global NK Cell Therapy Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global NK Cell Therapy Market Size Forecasted by Application (2027-2032)
- 3.3 Global NK Cell Therapy Market Size by Regions
- 3.3.1 North America NK Cell Therapy Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe NK Cell Therapy Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific NK Cell Therapy Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America NK Cell Therapy Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa NK Cell Therapy Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 NK Cell Therapy Industry Trends
- 4.2 NK Cell Therapy Industry Drivers
- 4.3 NK Cell Therapy Industry Opportunities and Challenges
- 4.4 NK Cell Therapy Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by NK Cell Therapy Revenue (2021-2026)
- 5.2 Global NK Cell Therapy Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global NK Cell Therapy Key Company Headquarters & Area Served
- 5.4 Global NK Cell Therapy Company, Product Type & Application
- 5.5 Global NK Cell Therapy Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global NK Cell Therapy Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 NK Cell Therapy Players Market Share by Revenue in 2025
- 5.6.3 2025 NK Cell Therapy Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Nektar Therapeutics
- 6.1.1 Nektar Therapeutics Company Information
- 6.1.2 Nektar Therapeutics Business Overview
- 6.1.3 Nektar Therapeutics NK Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Nektar Therapeutics NK Cell Therapy Product Portfolio
- 6.1.5 Nektar Therapeutics Recent Developments
- 6.2 Innate Pharma SA
- 6.2.1 Innate Pharma SA Company Information
- 6.2.2 Innate Pharma SA Business Overview
- 6.2.3 Innate Pharma SA NK Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Innate Pharma SA NK Cell Therapy Product Portfolio
- 6.2.5 Innate Pharma SA Recent Developments
- 6.3 Affimed
- 6.3.1 Affimed Company Information
- 6.3.2 Affimed Business Overview
- 6.3.3 Affimed NK Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Affimed NK Cell Therapy Product Portfolio
- 6.3.5 Affimed Recent Developments
- 6.4 Chipscreen Biosciences
- 6.4.1 Chipscreen Biosciences Company Information
- 6.4.2 Chipscreen Biosciences Business Overview
- 6.4.3 Chipscreen Biosciences NK Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Chipscreen Biosciences NK Cell Therapy Product Portfolio
- 6.4.5 Chipscreen Biosciences Recent Developments
- 6.5 Fate Therapeutics
- 6.5.1 Fate Therapeutics Company Information
- 6.5.2 Fate Therapeutics Business Overview
- 6.5.3 Fate Therapeutics NK Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Fate Therapeutics NK Cell Therapy Product Portfolio
- 6.5.5 Fate Therapeutics Recent Developments
- 6.6 Glycostem Therapeutics
- 6.6.1 Glycostem Therapeutics Company Information
- 6.6.2 Glycostem Therapeutics Business Overview
- 6.6.3 Glycostem Therapeutics NK Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Glycostem Therapeutics NK Cell Therapy Product Portfolio
- 6.6.5 Glycostem Therapeutics Recent Developments
- 6.7 Dragonfly Therapeutics
- 6.7.1 Dragonfly Therapeutics Company Information
- 6.7.2 Dragonfly Therapeutics Business Overview
- 6.7.3 Dragonfly Therapeutics NK Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Dragonfly Therapeutics NK Cell Therapy Product Portfolio
- 6.7.5 Dragonfly Therapeutics Recent Developments
- 6.8 Kiadis Pharma
- 6.8.1 Kiadis Pharma Company Information
- 6.8.2 Kiadis Pharma Business Overview
- 6.8.3 Kiadis Pharma NK Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Kiadis Pharma NK Cell Therapy Product Portfolio
- 6.8.5 Kiadis Pharma Recent Developments
- 6.9 NantWorks
- 6.9.1 NantWorks Company Information
- 6.9.2 NantWorks Business Overview
- 6.9.3 NantWorks NK Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 NantWorks NK Cell Therapy Product Portfolio
- 6.9.5 NantWorks Recent Developments
- 6.10 Nkarta Therapeutics
- 6.10.1 Nkarta Therapeutics Company Information
- 6.10.2 Nkarta Therapeutics Business Overview
- 6.10.3 Nkarta Therapeutics NK Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Nkarta Therapeutics NK Cell Therapy Product Portfolio
- 6.10.5 Nkarta Therapeutics Recent Developments
- 6.11 Fortress Biotech
- 6.11.1 Fortress Biotech Company Information
- 6.11.2 Fortress Biotech Business Overview
- 6.11.3 Fortress Biotech NK Cell Therapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Fortress Biotech NK Cell Therapy Product Portfolio
- 6.11.5 Fortress Biotech Recent Developments
7 North America
- 7.1 North America NK Cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America NK Cell Therapy Market Size by Country (2021-2026)
- 7.3 North America NK Cell Therapy Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe NK Cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe NK Cell Therapy Market Size by Country (2021-2026)
- 8.3 Europe NK Cell Therapy Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific NK Cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific NK Cell Therapy Market Size by Country (2021-2026)
- 9.3 Asia-Pacific NK Cell Therapy Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America NK Cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America NK Cell Therapy Market Size by Country (2021-2026)
- 10.3 South America NK Cell Therapy Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa NK Cell Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa NK Cell Therapy Market Size by Country (2021-2026)
- 11.3 Middle East & Africa NK Cell Therapy Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst